SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Emisphere -- Ignore unavailable to you. Want to Upgrade?

To: technetium who wrote (262)10/31/2006 9:55:52 PM
From: hmpa  Respond to of 272
 
If you are interested in the company (either way) you'll do yourself a huge favor if you listen to it. It's a long call (about 90 min., including ~1 hr of Q&A). You can get some idea from yesterday's YMB posts, but none of them provides a good summary. Note that the stock made it low for the day (on 10/30) BEFORE the cc.

Results were fairly good for the design used (you need a panacea to produce a good statistics there) and I think will let them partner the program, but the company grossly mismanaged expectations for many months - you saw the consequences in a stock price.



To: technetium who wrote (262)10/31/2006 10:11:13 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 272
 
investorshub.com



To: technetium who wrote (262)11/1/2006 6:47:47 AM
From: kenhott  Read Replies (2) | Respond to of 272
 
As you can see, people do have different feelings about this event. But my opinion is that you should be careful re: their oral insulin because they will need positive data from another trial for the right kind of companies to be interested in this product. I agree with hmpa that you should listen to the conference call if you are really interested.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News